Stomach Cancer
📧 Sign up to get email alerts when something new happens for Stomach Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer [NA]
This entry reports an ongoing clinical trial investigating whether using a stress ball affects nausea, anxiety, and fatigue in patients with…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Sigvotatug Vedotin in Advanced Solid Tumors [Phase 1]
Phase 1 study of Sigvotatug Vedotin in advanced solid tumors is currently recruiting. The trial targets multiple indications, including non-…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating SGN-CEACAM5C in adults with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Real-time Activity Monitoring to Prevent Admissions During RadioTherapy [NA]
A completed clinical trial evaluating real-time activity monitoring to reduce hospital admissions during radiotherapy in cancers of the head…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma [Phase 1]
Phase 1 clinical trial update for TNhYP218 anti-mesothelin CAR T cells in mesothelin-expressing solid tumors, including mesothelioma; recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2026-02-05Clinical Trial Update: The PLATON Network
The PLATON Network trial (NCT05489250), sponsored by IKF GmbH at Krankenhaus Nordwest, has been terminated; the study involved hepatocellula…
-
EMA approval · 2026-01-28EMA Authorised: Herzuma (trastuzumab) — Celltrion Healthcare Hungary Kft.
The EMA authorised Herzuma, a trastuzumab biosimilar from Celltrion Healthcare Hungary Kft, for stomach cancer and breast cancer in the EU.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
A first-in-human study of 3H-10000 in patients with unresectable or metastatic solid tumors is currently in Phase 1/Phase 2 and actively rec…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A prospective observational validation of a cfDNA assay for early cancer detection and minimal residual disease is currently recruiting acro…
-
EMA approval · 2026-01-19EMA Authorised: Zercepac (trastuzumab) — Accord Healthcare S.L.U.
The EMA authorised Zercepac, a trastuzumab biosimilar from Accord Healthcare S.L.U., for breast cancer and stomach cancer.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Robotic Gastrectomy With 5th Arm [NA]
A ClinicalTrials.gov entry shows a recruiting study from The Chinese University of Hong Kong evaluating robotic gastrectomy with a fifth arm…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Ongoing Stanford University clinical trial evaluating clinical and pathological aspects of upper gastrointestinal cancers, including stomach…
-
EMA approval · 2025-10-30EMA Authorised: Teysuno (tegafur;gimeracil;oteracil) — Nordic Group B.V.
The EMA authorised Teysuno, a fixed-dose combination of tegafur, gimeracil and oteracil, for stomach cancer. The marketing authorisation hol…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of ESG401 in Adults With Solid Tumors [Phase 1, Phase 2]
Clinical trial update on ESG401 in adults with solid tumors, spanning Phase 1 and Phase 2. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
The DELFI-L101 study from Delfi Diagnostics, which evaluates DNA fragment analysis for early interception of cancer, has completed enrollmen…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Laparotomy, Laparoscopy, da Vinci System
Completed clinical trial evaluating laparotomy, laparoscopy, and robotic da Vinci System approaches for stomach and pancreatic neoplasms, as…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Brodalumab in the Treatment of Immune-Related Adverse Events [Phase 1]
Phase 1 study of brodalumab for treatment of immune-related adverse events in cancer patients. The trial is currently recruiting across mult…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) [Phase 2]
Phase 2 study evaluating IMU-131 (HER-Vaxx) with chemotherapy or pembrolizumab in metastatic HER2-overexpressing gastric cancer; the trial w…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Early IntraVenous Administration of Nutritional Support [NA]
The clinical trial evaluating early intravenous administration of nutritional support in patients with stomach cancer and gastroesophageal c…
-
EMA approval · 2025-05-05EMA Authorised: Capecitabine Accord (capecitabine) — Accord Healthcare S.L.U.
The EMA authorised Capecitabine Accord (capecitabine) by Accord Healthcare S.L.U. for breast cancer, colorectal cancer, and stomach cancer, …
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection [Phase 2]
A Phase 2 clinical trial evaluating the use of Indocyanine Green tracer during laparoscopic gastrectomy with lymph node dissection for stoma…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of SGN-ALPV in Advanced Solid Tumors [Phase 1]
Seagen's Phase 1 study of SGN-ALPV in advanced solid tumors has been terminated; the trial evaluated multiple cancers including ovarian, end…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the combination of tumor-infiltrating lymphocyte (TIL) therapy with pembro…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES) [NA]
This clinical trial investigates the effect of exercise and diet on quality of life in patients with incurable cancer of the esophagus and s…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients [Phase 2]
Phase 2 study evaluating second-line ramucirumab with or without paclitaxel in elderly patients with advanced gastric or gastroesophageal ju…